Resource stratified guidelines for cancer: Are they all the same? Interguideline concordance for systemic treatment recommendations-Reference-Cited by-同舟云学术

Resource stratified guidelines for cancer: Are they all the same? Interguideline concordance for systemic treatment recommendations

Published:2021-08-25 Issue:1 Volume:150 Page:91-99
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Wilson Brooke E.¹²^ORCID,Elliott Mitchell J.²,Pearson Sallie‐Anne³⁴,Amir Eitan²,Barton Michael B.¹

Affiliation:

1. Collaboration for Cancer Outcomes, Research and Evaluation South West Clinical School, University of New South Wales Sydney New South Wales Australia

2. Princess Margaret Hospital University of Toronto Toronto Ontario Canada

3. Centre for Big Data Research in Health, UNSW Sydney Australia

4. Menzies Centre for Health Policy University of Sydney Sydney Australia

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33764

Reference44 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study

3. Why Don't Physicians Follow Clinical Practice Guidelines?

4. Factors influencing the implementation of clinical guidelines for health care professionals: A systematic meta-review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement;The Lancet Oncology;2023-06

2. Radiotherapy prioritization in 143 national cancer control plans: Correlation with radiotherapy machine availability, geography and income level;Radiotherapy and Oncology;2022-11

3. Global Inequity and its Consequences in Radiation Oncology Research;International Journal of Radiation Oncology*Biology*Physics;2022-07

4. Prioritising access to cancer drugs;The Lancet Oncology;2022-01